BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23072022)

  • 1. States renewing attention to prostate cancer.
    Rossiter C
    NCSL Legisbrief; 2012 Sep; 20(36):1-2. PubMed ID: 23072022
    [No Abstract]   [Full Text] [Related]  

  • 2. Risks of PSA screening now better understood.
    Peres J
    J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
    [No Abstract]   [Full Text] [Related]  

  • 3. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 4. Can we stop ordering prostate-specific antigen screening tests?
    Katz MH
    JAMA Intern Med; 2013 May; 173(10):847-8. PubMed ID: 23588841
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
    Belpomme D; Irigaray P
    J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
    [No Abstract]   [Full Text] [Related]  

  • 6. [Authorities in USA don't recommend screening for prostate cancer].
    Bratt O
    Lakartidningen; 2011 Nov 16-22; 108(46):2362. PubMed ID: 22468374
    [No Abstract]   [Full Text] [Related]  

  • 7. Lung cancer screening gets risk-specific.
    Peres J
    J Natl Cancer Inst; 2013 Jan; 105(1):1-2. PubMed ID: 23257155
    [No Abstract]   [Full Text] [Related]  

  • 8. New PSA guidelines discourage overscreening.
    Peres J
    J Natl Cancer Inst; 2012 Jan; 104(1):8-9. PubMed ID: 22173585
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigation momentum: the relentless pursuit to resolve uncertainty.
    Sah S; Elias P; Ariely D
    JAMA Intern Med; 2013 May; 173(10):932-3. PubMed ID: 23588200
    [No Abstract]   [Full Text] [Related]  

  • 10. [New developments in diagnosis and therapy of prostate cancer--from "active surveillance" to robotic-assisted surgery].
    Krome S
    Dtsch Med Wochenschr; 2011 Oct; 136 Suppl 3():S86-9. PubMed ID: 21960373
    [No Abstract]   [Full Text] [Related]  

  • 11. [Systematic PSA screening has been tried in Region Skåne. Balanced information gives chance for equal treatment according to a pilot project].
    Bratt O; Lundgren R; Ahlgren G
    Lakartidningen; 2012 Sep 12-18; 109(37):1610-2. PubMed ID: 23077769
    [No Abstract]   [Full Text] [Related]  

  • 12. Early detection of prostate cancer.
    Taneja SS
    Urol Clin North Am; 2014 May; 41(2):xi-xii. PubMed ID: 24725495
    [No Abstract]   [Full Text] [Related]  

  • 13. Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Ann Intern Med; 2013 May; 158(10):I-28. PubMed ID: 23567761
    [No Abstract]   [Full Text] [Related]  

  • 14. [Large part of Swedish men PSA tested for early prostatic cancer. Few aware of the disadvantages of the test].
    Bratt O; Grenabo L
    Lakartidningen; 2010 Feb 17-23; 107(7):432-5. PubMed ID: 20384075
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informed prostate cancer risk-adjusted testing: a new paradigm.
    Stricker PD; Frydenberg M; Kneebone A; Chopra S
    BJU Int; 2012 Dec; 110 Suppl 4():30-4. PubMed ID: 23194122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Legal (liability) aspects of PSA determination].
    Mielke K
    Urologe A; 2006 Jun; 45(6):756-65. PubMed ID: 16788794
    [No Abstract]   [Full Text] [Related]  

  • 18. The Melbourne Consensus Statement on the early detection of prostate cancer.
    Murphy DG; Ahlering T; Catalona WJ; Crowe H; Crowe J; Clarke N; Cooperberg M; Gillatt D; Gleave M; Loeb S; Roobol M; Sartor O; Pickles T; Wootten A; Walsh PC; Costello AJ
    BJU Int; 2014 Feb; 113(2):186-8. PubMed ID: 24206066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.
    Kwiatkowski M; Klotz L; Hugosson J; Recker F
    Eur Urol; 2012 Apr; 61(4):851-4. PubMed ID: 22285762
    [No Abstract]   [Full Text] [Related]  

  • 20. Why prostate cancer screening is necessary.
    Witte MN; Lindaman BD; Rosinsky DE
    S D Med; 2015; Spec No():88-91. PubMed ID: 25985616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.